Category Archives: Pharmaceuticals & Healthcare

Estrogen Receptor Positive (ER+) Breast Cancer – Treatment Landscape & Competitive Analysis

Breast CancerEstrogen Receptor Positive (ER+) Breast Cancer – Treatment Landscape & Competitive Analysis, 2017, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the Estrogen Receptor Positive (ER+) Breast Cancer, epidemiology, risk factors, diagnosis etc. A key objective of the report is to establish the understanding of the treatment landscape and competitive analysis of the Estrogen Receptor Positive (ER+) Breast Cancer which mainly describes the treatment of breast cancer at different stages. Breast cancer is the condition where the cells of the breast area become tumorous, that is, they undergo unlimited cell division. Both women and men are affected but chances of men being diagnosed with breast cancer are rare. Each year about 2,300 new cases of breast cancer in men and about 230,000 new cases in women are diagnosed. It is the second most common cancer among women in USA.

Request for Sample Market Report @http://www.aarkstore.com/sample/479514

This report provides the insights of the marketed drugs for the Estrogen Receptor Positive (ER+) Breast Cancer which includes the Targeted Therapy, Hormone Therapy and Chemotherapy. In case of Estrogen Receptor Positive (ER+) Breast Cancer, Hormone therapy is the main focus of treatment after surgery and chemotherapy. Hormonal therapy is usually recommended after 5 years of surgery and can be divided into Estrogen blocking hormonal therapy and estrogen lowering hormonal therapy based on the mechanism of action of the hormonal therapy drugs. Of all the late-stage pipeline drugs, Buparlisib is expected to reach the market in the next few years.
Recent report  covers the treatment landscape which provides the treatment options by different stages and type of the breast cancer. There are four chemotherapy drugs, six hormone therapy drugs and one targeted therapy drugs in market for the treatment of Estrogen Receptor Positive (ER+) Breast Cancer.

Report Highlights:

The new report, provides a Estrogen Receptor Positive (ER+) Breast Cancer Treatment Landscape across the globe
The report provides profiles of the marketed drug which includes the product description, cost of treatment, development partner, patent expiry date, sales data etc.
Comparative analysis of marketed drugs by therapy, cost of treatment, Therapeutic Class. Coverage of the Estrogen Receptor Positive (ER+) Breast Cancer Phase III and Pre-registration Drugs Analysis by product type, molecule type, route of administration, Median Progression Free Survival
The report reviews key players involved in the therapeutics development for Estrogen Receptor Positive (ER+) Breast Cancer and also provide market barriers, market drivers and opportunities
Provides Phase III products assessment by line of therapy and target.

Related Market Research Reports:

Global Selective Estrogen Receptor Modulator Sales Market Report 2016

United States Selective Estrogen Receptor Modulator Market Report 2016

Europe Selective Estrogen Receptor Modulator Market Report 2016

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Advertisements

United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.

insulin-pumpMarket growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

Request for Sample Market Report @http://www.aarkstore.com/sample/425976

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation

TABLE  OF  CONTENTS        

1. Executive Summary 

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes

3. United States Insulin Pump Market Analysis (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market

4. Key Drivers and Inhibitors of the United States Insulin Pump Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Insulin Pump Preferred Brand – By Product
5.1 Pediatric
5.2 Adult

Related Market Research Reports

United States X-Ray Safety Glasses Market Report 2017

United Kingdom (UK) Proton Therapy Market, Reimbursement Policy, Patients Treated at Proton Facility & Forecast

About Aarkstore:

Aarkstore Enterprise is among global marketing research companies involved in selling market reports across different industries and countries. We help serve thousands of clients annually with syndicated, custom market research and consulting. Collaborating with renowned market research partners, we have continued to etch our presence as an established as channel sales partner of market research intelligence on various frontiers. Clients from all sectors, including public, private, and commercial are endowed with best data modelling and processing structures with custom reports.

For further details, please Contact Us

Contract Research Organization Deals Hit Almost $10 Billion

Contract Research Organization Market – Global Deals and Operational Strategies

The total number of deals in the global Contract Research Organization (CRO) market reached 700 between January 2010 and April 2015, achieving an overall value of $33 billion. 2015 has already contributed the most to the overall deals value during this period, with $9.86 billion achieved between January and April this year alone, representing an almost fourfold increase from the $2.5 billion reached in 2014. This impressive growth was significantly bolstered by Laboratory Corporation of America’s (LabCorp) record $6.1 billion acquisition of Covance in February 2015, enabling LabCorp to strengthen its laboratory and CRO service offerings. In its bid to acquire Covance, the company also issued debt offerings of $2.9 billion.

Contract Research Organization Market: Global Deals and Operational Strategies report discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than forty public and privately held CROs.

http://www.aarkstore.com/pharmaceuticals-healthcare/126162/contract-research-organization-market-global-deals-and-operational-strategies

The scope of the report includes:

• Overview of key reasons behind outsourcing, outsourcing service models

• Examples of operational strategies

• Global deals analysis by type and value

• Major acquisitions and partnerships

• Regional analysis of North America, Europe, Asia-Pacific and emerging markets

• SWOT analysis and profiles of key players

Get a company benchmark heatmap analyses for over thirty key players listing their operational strategies.

Publisher : CBR Pharma Insights | Report Available with Aarkstore.com

PharmaSphere: Emerging Biotechnologies – Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies – Stem Cell Therapy”, provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as China, India, SouthKorea, and Israel-providing in-depth analysis of these markets regulatory framework, key domestic players and their stem cell pipelines, and strategic outlook.

What else will you gain from this report?

  • Stem Cell Market Dynamics: Key drivers and trends shaping the market, including manufacturing, emerging markets, and development pipeline
  • Financial Performance Insight: Use of 22 key financial metrics to provide insight over stem cell company performance
  • Pipeline Analysis: Detailed information on ten leading stem cell therapies; trend analysis of clinical trial studies and investigators covering over 1000 related trials
  • Deal strategies: Exhaustive discussion on the strategic implications and synergies of deals including, M&A, collaboration as well as capital raisings such as equity offerings, private equity and venture financing activities
  • Regulatory Implications: Guidelines for stem cell usage for developing therapies in seven major markets including US, Europe, Japan, South Korea, Israel, China and India
  • Company Analysis: Competitive landscape covering 40 companies on full pipeline, financials and key overview information

link for more information : http://www.aarkstore.com/pharmaceuticals-healthcare/62815/pharmasphere-emerging-biotechnologies-stem-cell-therapy

2015 Strategies in the Italian Hematology and Flow Cytometry Markets

This comprehensive report contains 250 pages, 32 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in Italian hematology and flow cytometry markets during the next five years.

The report explores business and technological trends in the Italian hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.

For full report click here : http://www.aarkstore.com/pharmaceuticals-healthcare/118083/strategies-in-the-italian-hematology-and-flow-cytometry-markets

%d bloggers like this: